Novo Nordisk A S (NVO) EPS (Basic) (2012 - 2016)
Novo Nordisk A S's (NVO) quarterly EPS (Basic) came in at $0.29 in Q2 2016, up 26.65% YoY from $0.23 in Q3 2015, and up 8.24% on a QoQ basis from $0.27 in Q1 2016.
Novo Nordisk A S (NVO) EPS (Basic) (2012 - 2016) Analysis & Trends
Novo Nordisk A S (NVO) has 5 years of EPS (Basic) data on file, last reported at $0.29 in Q2 2016.
- Quarterly EPS (Basic) rose 26.65% year-over-year to $0.29 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.04 (up 11.49% YoY) and the FY2019 annual result came in at $37.5, up 14.86% from the prior year.
- EPS (Basic) improved to $0.29 in Q2 2016, from $0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.29 in Q2 2016 to a low of $0.19 in Q1 2012.
- A 5-year average of $0.24 and a median of $0.24 in 2015 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2013 — EPS (Basic) jumped 32.36% — and 2014, when it slipped 23.35%.
- Tracing NVO's EPS (Basic) over 5 years: stood at $0.24 in 2012, then advanced by 12.37% to $0.27 in 2013, then fell by 23.35% to $0.21 in 2014, then increased by 14.54% to $0.24 in 2015, then grew by 24.88% to $0.29 in 2016.
- The last three EPS (Basic) figures came in at $0.29 (Q2 2016), $0.27 (Q1 2016), and $0.24 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 0.29 |
| Mar 31, 2016 | 0.27 |
| Dec 31, 2015 | 0.24 |
| Sep 30, 2015 | 0.24 |
| Jun 30, 2015 | 0.23 |
| Mar 31, 2015 | 0.28 |
| Dec 31, 2014 | 0.21 |
| Sep 30, 2014 | 0.22 |
| Jun 30, 2014 | 0.24 |
| Mar 31, 2014 | 0.22 |
| Dec 31, 2013 | 0.27 |
| Sep 30, 2013 | 0.28 |
| Jun 30, 2013 | 0.28 |
| Mar 31, 2013 | 0.25 |
| Dec 31, 2012 | 0.24 |
| Sep 30, 2012 | 0.23 |
| Jun 30, 2012 | 0.22 |
| Mar 31, 2012 | 0.19 |